Arvinas, Inc.
USD8.29
+0.29 (+3.63%)
CEO
Randy Teel
IPO Date
2018-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.05
Prev. Close
$8.00
Day Low
$8.00
Day High
$8.62
52W Low
$6.06
52W High
$14.51
Market Cap
$0.53B
Volume
0.93M
| -6.9 |
| 31 Dec 2023 | FY | 100.0% | -467.9% | -55.7% | -28.2% | 0.00 | 4.98 | -6.2 |
| 31 Dec 2022 | FY | 100.0% | -215.0% | -50.0% | -22.3% | 0.01 | 4.20 | -6.4 |
| 31 Dec 2021 | FY | 100.0% | -356.3% | -24.4% | -12.1% | 0.01 | 5.93 | -21.5 |
| 31 Dec 2020 | FY | 100.0% | -460.6% | -18.6% | -16.6% | 0.01 | 14.29 | -28.1 |
| 31 Dec 2019 | FY | 100.0% | -163.6% | -31.0% | -23.3% | 0.02 | 8.86 | -19.2 |
| 31 Dec 2018 | FY | 100.0% | -289.6% | -30.4% | -20.8% | 0.02 | 8.52 | -9.8 |
| 31 Dec 2017 | FY | 100.0% | -317.3% | -9781.3% | -36.0% | 1.26 | 3.67 | -13.8 |
| 31 Dec 2016 | FY | 100.0% | -215.2% | -59.7% | -37.8% | 0.02 | 3.72 | -2.1 |
| -2.9 |
| 30 Sept 2025 | Q3 | 100.0% | -83.8% | -6.2% | -4.2% | 0.02 | 5.70 | -4.4 |
| 30 Jun 2025 | Q2 | 100.0% | -273.2% | -10.0% | -6.7% | 0.02 | 5.64 | -2.2 |
| 31 Mar 2025 | Q1 | 100.0% | 43.9% | 12.6% | 8.3% | 0.02 | 4.58 | 1.5 |
| 31 Dec 2024 | Q4 | 100.0% | -76.2% | -8.0% | -4.1% | 0.02 | 4.64 | -7.7 |
| 30 Sept 2024 | Q3 | 100.0% | -48.0% | -8.4% | -4.2% | 0.00 | 4.17 | -9.0 |
| 30 Jun 2024 | Q2 | 97.8% | -46.0% | -5.9% | -2.8% | 0.00 | 3.62 | -13.3 |
| 31 Mar 2024 | Q1 | 93.3% | -274.3% | -11.4% | -5.7% | 0.00 | 4.94 | -10.4 |
| 31 Dec 2023 | Q4 | 103.9% | 359.2% | -23.5% | -11.9% | 0.00 | 4.98 | -4.1 |